Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

BRISTOL
FDA Approves Unknown Drug — BRISTOL MYERS SQUIBB

On December 28, 2012, the FDA granted approval to a new drug from Bristol-Myers Squibb, a move that may broaden the company's portfolio and influence ...

Par
FDA Approves LAMOTRIGINE EXTENDED-RELEASE — Par Health USA, LLC

Par Health USA, LLC received final FDA approval for the LAMOTRIGINE extended-release (ANDA201374), placing the company in direct competition with esta...

Takeda
FDA Approves GATTEX — Takeda Pharmaceuticals America, Inc.

On December 21, 2012, the FDA approved TEDUGLUTIDE (Subcutaneous), developed by Takeda Pharmaceuticals America, Inc., for the treatment of short bowel...

Micro
FDA Approves TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Micro Labs Limited

Micro Labs Limited secured FDA approval for its Tramadol Hydrochloride and Acetaminophen oral tablet formulation, expanding its product portfolio in t...

Par
FDA Approves ADRENALIN — Par Health USA, LLC

On December 7, 2012, Par Health USA, LLC received FDA approval for its NDA for ADRENALIN (epinephrine) 1 mg/mL intramuscular injection, a generic equi...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS ELIZABETH

On November 30, 2012, generic drug distributor ACTAVIS ELIZABETH received FDA approval for the Abbreviated New Drug Application (ANDA203901), signalin...

IPCA
FDA Approves Unknown Drug — IPCA LABS LTD

IPCA Laboratories Ltd. has received FDA approval for its Abbreviated New Drug Application #ANDA201973, marking a potential entry into the U.S. market ...

Pfizer
FDA Approves XELJANZ — Pfizer Laboratories Div Pfizer Inc

FDA approved XELJANZ (tofacitinib citrate) from Pfizer Laboratories, a new oral treatment for rheumatoid arthritis, paving the way for the company to ...

Par
FDA Approves OLANZAPINE AND FLUOXETINE — Par Health USA, LLC

# FDA Approves Par Pharmaceutical's Generic Olanzapine and Fluoxetine Combination Par Pharmaceutical's approval of generic olanzapine and fluoxetine ...

COLLEGIUM
FDA Approves Unknown Drug — COLLEGIUM PHARM INC

Collegium Pharmaceutical has avoided a significant regulatory setback with a late-stage FDA pushing back a review for NexaFilm (aluminum hydroxide coa...

RISING
FDA Approves Unknown Drug — RISING

Rising has received FDA approval for ANDA200144, triggering expectations of increased competition in the [insert substance category] market. The appro...

Heritage
FDA Approves COLISTIMETHATE SODIUM — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has been granted FDA approval for the INTRAMUSCULAR formulation of Colistimethate Sodium...

NextWave
FDA Approves QUILLIVANT XR — NextWave Pharmaceuticals, Inc

# FDA Approves NextWave Pharmaceuticals' QUILLIVANT XR for ADHD Treatment NextWave Pharmaceuticals, Inc. received FDA approval for QUILLIVANT XR (met...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for ANDA 077446 on September 27, 2012, expanding its generic pharmaceutic...

Micro
FDA Approves LOSARTAN POTASSIUM — Micro Labs Limited

# FDA Approves Losartan Potassium Generic from Micro Labs Limited Micro Labs Limited has received FDA approval for its generic formulation of losarta...

Lupin
FDA Approves ESCITALOPRAM — Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals, Inc. secured FDA approval for generic Escitalopram Oxalate oral tablets, expanding its portfolio in the widely utilized antidep...

Chartwell
FDA Approves ZIPRASIDONE — Chartwell RX, LLC

# FDA Approval Newswire The FDA has approved Chartwell RX, LLC's generic formulation of Ziprasidone Hydrochloride for oral administration, expanding ...

Astellas
FDA Approves XTANDI — Astellas Pharma US, Inc.

Astellas Pharma US, Inc. received FDA approval for XTANDI (enzalutamide), an oral medication for prostate cancer, which historically generated over $4...

Aurobindo
FDA Approves ALFUZOSIN HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma Limited received FDA approval for the generic formulation of its ALFUZOSIN HYDROCHLORIDE oral tablets, broadening the company’s portf...

Macleods
FDA Approves LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Macleods Pharmaceuticals Limited

# FDA Approves Generic Losartan Potassium and Hydrochlorothiazide Combination Macleods Pharmaceuticals Limited received FDA approval for its generic ...